Synthesis and Pharmacokinetic Evaluation of Siderophore Biosynthesis Inhibitors for Mycobacterium tuberculosis
Тип публикации: Journal Article
Дата публикации: 2015-07-09
SCImago Q1
Tоп 10% SCImago
WOS Q1
БС1
SJR: 1.726
CiteScore: 11.1
Impact factor: 7.3
ISSN: 00222623, 15204804
PubMed ID:
26110337
Drug Discovery
Molecular Medicine
Краткое описание
MbtA catalyzes the first committed biosynthetic step of the mycobactins, which are important virulence factors associated with iron acquisition in Mycobacterium tuberculosis. MbtA is a validated therapeutic target for antitubercular drug development. 5'-O-[N-(Salicyl)sulfamoyl]adenosine (1) is a bisubstrate inhibitor of MbtA and exhibits exceptionally potent biochemical and antitubercular activity. However, 1 suffers from suboptimal drug disposition properties resulting in a short half-life (t(1/2)), low exposure (AUC), and low bioavailability (F). Four strategies were pursued to address these liabilities including the synthesis of prodrugs, increasing the pK(a) of the acyl-sulfonyl moiety, modulation of the lipophilicity, and strategic introduction of fluorine into 1. Complete pharmacokinetic (PK) analysis of all compounds was performed. The most successful modifications involved fluorination of the nucleoside that provided substantial improvements in t(1/2) and AUC. Increasing the pK(a) of the acyl-sulfonyl linker yielded incremental enhancements, while modulation of the lipophilicity and prodrug approaches led to substantially poorer PK parameters.
Найдено
Ничего не найдено, попробуйте изменить настройки фильтра.
Для доступа к списку цитирований публикации необходимо авторизоваться.
Для доступа к списку профилей, цитирующих публикацию, необходимо авторизоваться.
Топ-30
Журналы
|
1
2
|
|
|
Molecules
2 публикации, 7.14%
|
|
|
International Journal of Molecular Sciences
2 публикации, 7.14%
|
|
|
Bioorganic and Medicinal Chemistry
2 публикации, 7.14%
|
|
|
Bioorganic and Medicinal Chemistry Letters
2 публикации, 7.14%
|
|
|
ChemMedChem
2 публикации, 7.14%
|
|
|
ACS Medicinal Chemistry Letters
1 публикация, 3.57%
|
|
|
Journal of Biological Inorganic Chemistry
1 публикация, 3.57%
|
|
|
Journal of Antibiotics
1 публикация, 3.57%
|
|
|
Clinical Pharmacokinetics
1 публикация, 3.57%
|
|
|
Russian Chemical Reviews
1 публикация, 3.57%
|
|
|
Journal of Biological Chemistry
1 публикация, 3.57%
|
|
|
Drug Discovery Today
1 публикация, 3.57%
|
|
|
Carbohydrate Research
1 публикация, 3.57%
|
|
|
Angewandte Chemie
1 публикация, 3.57%
|
|
|
Angewandte Chemie - International Edition
1 публикация, 3.57%
|
|
|
Biochemistry
1 публикация, 3.57%
|
|
|
ACS Infectious Diseases
1 публикация, 3.57%
|
|
|
Journal of Medicinal Chemistry
1 публикация, 3.57%
|
|
|
Methods in Enzymology
1 публикация, 3.57%
|
|
|
RSC Medicinal Chemistry
1 публикация, 3.57%
|
|
|
Pharmaceuticals
1 публикация, 3.57%
|
|
|
European Journal of Medicinal Chemistry
1 публикация, 3.57%
|
|
|
ChemBioChem
1 публикация, 3.57%
|
|
|
1
2
|
Издатели
|
1
2
3
4
5
6
7
8
|
|
|
Elsevier
8 публикаций, 28.57%
|
|
|
MDPI
5 публикаций, 17.86%
|
|
|
Wiley
5 публикаций, 17.86%
|
|
|
American Chemical Society (ACS)
4 публикации, 14.29%
|
|
|
Springer Nature
3 публикации, 10.71%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
1 публикация, 3.57%
|
|
|
American Society for Biochemistry and Molecular Biology
1 публикация, 3.57%
|
|
|
Royal Society of Chemistry (RSC)
1 публикация, 3.57%
|
|
|
1
2
3
4
5
6
7
8
|
- Мы не учитываем публикации, у которых нет DOI.
- Статистика публикаций обновляется еженедельно.
Вы ученый?
Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Войти с ORCID
Метрики
28
Всего цитирований:
28
Цитирований c 2025:
2
(7.14%)
Цитировать
ГОСТ |
RIS |
BibTex |
MLA
Цитировать
ГОСТ
Скопировать
Nelson K. et al. Synthesis and Pharmacokinetic Evaluation of Siderophore Biosynthesis Inhibitors for Mycobacterium tuberculosis // Journal of Medicinal Chemistry. 2015. Vol. 58. No. 14. pp. 5459-5475.
ГОСТ со всеми авторами (до 50)
Скопировать
Nelson K., Viswanathan K., Dawadi S., Duckworth B. P., Boshoff H., Barry C. E., Aldrich C. C. Synthesis and Pharmacokinetic Evaluation of Siderophore Biosynthesis Inhibitors for Mycobacterium tuberculosis // Journal of Medicinal Chemistry. 2015. Vol. 58. No. 14. pp. 5459-5475.
Цитировать
RIS
Скопировать
TY - JOUR
DO - 10.1021/acs.jmedchem.5b00391
UR - https://doi.org/10.1021/acs.jmedchem.5b00391
TI - Synthesis and Pharmacokinetic Evaluation of Siderophore Biosynthesis Inhibitors for Mycobacterium tuberculosis
T2 - Journal of Medicinal Chemistry
AU - Nelson, Kathryn
AU - Viswanathan, Kishore
AU - Dawadi, Surendra
AU - Duckworth, Benjamin P.
AU - Boshoff, Helena
AU - Barry, Clifton E.
AU - Aldrich, Courtney C.
PY - 2015
DA - 2015/07/09
PB - American Chemical Society (ACS)
SP - 5459-5475
IS - 14
VL - 58
PMID - 26110337
SN - 0022-2623
SN - 1520-4804
ER -
Цитировать
BibTex (до 50 авторов)
Скопировать
@article{2015_Nelson,
author = {Kathryn Nelson and Kishore Viswanathan and Surendra Dawadi and Benjamin P. Duckworth and Helena Boshoff and Clifton E. Barry and Courtney C. Aldrich},
title = {Synthesis and Pharmacokinetic Evaluation of Siderophore Biosynthesis Inhibitors for Mycobacterium tuberculosis},
journal = {Journal of Medicinal Chemistry},
year = {2015},
volume = {58},
publisher = {American Chemical Society (ACS)},
month = {jul},
url = {https://doi.org/10.1021/acs.jmedchem.5b00391},
number = {14},
pages = {5459--5475},
doi = {10.1021/acs.jmedchem.5b00391}
}
Цитировать
MLA
Скопировать
Nelson, Kathryn, et al. “Synthesis and Pharmacokinetic Evaluation of Siderophore Biosynthesis Inhibitors for Mycobacterium tuberculosis.” Journal of Medicinal Chemistry, vol. 58, no. 14, Jul. 2015, pp. 5459-5475. https://doi.org/10.1021/acs.jmedchem.5b00391.
Ошибка в публикации?